O. David
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
O. David has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
A. Grillo
Department of Clinical Pathology, S. Giovanni Battista Hospital, Turin, Italy
1 shared publicationB. Ceoloni
Department of Clinical Pathology, Regina Margherita–S. Anna Hospital, Turin, Italy
1 shared publicationC. Canavese
Department of Nephro‐Urology, Amedeo Avogadro University, Maggiore Hospital of Novara, Italy
1 shared publicationD. Bergamo
Department of Nephro‐Urology, Amedeo Avogadro University, Maggiore Hospital of Novara, Italy
1 shared publicationF. Cavallo
Department of Clinical Pathology, S. Giovanni Battista Hospital, Turin, Italy
1 shared publicationG. Podda
Department of Nephro‐Urology, Amedeo Avogadro University, Maggiore Hospital of Novara, Italy
1 shared publication
Latest Publications
- 1 January 2006
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 66 (2) , 113-120
Analysis of red cell parameters on the Sysmex XE 2100 and ADVIA 120 in iron deficiency and in uraemic chronic disease
Objective. The percentage measurement of hypochromic red cells (HYPO) and reticulocyte haemoglobin content (CHr) using the ADVIA system has recently been validated as a useful tool in indicating iron deficiency, also in cases of chronic diseases such as renal failure. The aim of this study was to evaluate the extent to which the red cell parameters, RBC‐Y and RET‐Y, provided by Sysmex XE 2100, correlate with HYPO and CHr. Material and methods. The laboratory markers of iron status were evaluated together with HYPO, CHr, RBC‐Y and RET‐Y in 92 healthy subjects (C), 42 iron‐deficient patients (ID) and 88 uraemic patients receiving regular dialysis treatment (RDT). Results. In ID patients, increased HYPO and decreased RBC‐Y, CHr and RET‐Y values, with no overlapping with reference values, were found and a significant correlation was present between ADVIA 120 and Sysmex indices (ppConclusions. This study confirmed the validity of RBC‐Y in the management of ID, but not in RDT, where the diagnostic power of RBC‐Y as an index of cell hypochromia is limited owing to high MCV values.
- 1 January 2006
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 66 (2) , 113-120
Analysis of red cell parameters on the Sysmex XE 2100 and ADVIA 120 in iron deficiency and in uraemic chronic disease
Objective. The percentage measurement of hypochromic red cells (HYPO) and reticulocyte haemoglobin content (CHr) using the ADVIA system has recently been validated as a useful tool in indicating iron deficiency, also in cases of chronic diseases such as renal failure. The aim of this study was to evaluate the extent to which the red cell parameters, RBC‐Y and RET‐Y, provided by Sysmex XE 2100, correlate with HYPO and CHr. Material and methods. The laboratory markers of iron status were evaluated together with HYPO, CHr, RBC‐Y and RET‐Y in 92 healthy subjects (C), 42 iron‐deficient patients (ID) and 88 uraemic patients receiving regular dialysis treatment (RDT). Results. In ID patients, increased HYPO and decreased RBC‐Y, CHr and RET‐Y values, with no overlapping with reference values, were found and a significant correlation was present between ADVIA 120 and Sysmex indices (ppConclusions. This study confirmed the validity of RBC‐Y in the management of ID, but not in RDT, where the diagnostic power of RBC‐Y as an index of cell hypochromia is limited owing to high MCV values.